Related Experiment Videos
Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
Journal of the National Cancer Institute
|December 6, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Cancer research·2001
The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research·2000
A new microsimulation model of HPV natural history for comparison of novel cervical screening strategies.
Journal of the National Cancer Institute·2026
Advancing opportunities for collaboration between national cancer Institute-Designated cancer centers and native nations: Building of an indigenous cancer health department.
Journal of the National Cancer Institute·2026
The early-onset pancreatic cancer paradox: a systematic review and meta-analysis.
Journal of the National Cancer Institute·2026
A validated clinical calculator of a brain metastasis risk (BrMR) prediction model in stage I-III breast cancer patients.
Journal of the National Cancer Institute·2026
Clinical and lifetime natural history of oral cancer: implications for screening and surveillance.
Journal of the National Cancer Institute·2026
21-Gene recurrence score assay in pN2-3 Early-Stage breast cancer: a national cancer database study.
Journal of the National Cancer Institute·2026
ATF4 and SLC7A11 as biomarkers predicting progression and prognosis in lung adenocarcinoma.
Frontiers in oncology·2026
Lactate metabolism and lactylation in uveal melanoma: from metabolic adaptation to immune regulation.
Frontiers in immunology·2026